Lunch presentation at DNB
September 25, 2018
Corporate presentation by Jakob Lindberg, CEO, Oncopeptides AB (publ), at DNB 25 September 2018.
Menu
-
Change Region
-
Global
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
-
Spain
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es
-
United States
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our US operations at oncopeptides-us.com
Change Language
-
-
ONCO2.2 SEK-4.8%-0.11 SEK
-
-
Change Region
-
Global
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
-
Spain
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es
-
United States
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our US operations at oncopeptides-us.com
Change Language
-
-
ONCO2.2 SEK-4.8%-0.11 SEK
-